본문 바로가기
KERD
논문KCI 등재

Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets

Cheryl D. Bushnell|Christine Tschoe|Pamela W. Duncan|Martha A. Alexander-Miller|Stacey Q. Wolfe
대한뇌졸중학회 (The Korean Stroke Society)|2020.01|대한뇌졸중영문학회지 (Journal of stroke)|제22권 제1호|pp. 29-46|DOI https://doi.org/10.5853/jos.2019.02236

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

StrokeImmunomodulationCerebral hemorrhageNeuroinflammationProgrammed death-1Fingolimod hydrochloride
주제분류신경과학

초록

Spontaneous intracerebral hemorrhage (ICH) is a catastrophic illness causing significant morbidity and mortality. Despite advances in surgical technique addressing primary brain injury caused by ICH, little progress has been made treating the subsequent inflammatory cascade. Pre-clinical studies have made advancements identifying components of neuroinflammation, including microglia, astrocytes, and T lymphocytes. After cerebral insult, inflammation is initially driven by the M1 microglia, secreting cytokines (e.g., interleukin-1β [IL-1β] and tumor necrosis factor-α) that are involved in the breakdown of the extracellular matrix, cellular integrity, and the blood brain barrier. Additionally, inflammatory factors recruit and induce differentiation of A1 reactive astrocytes and T helper 1 (Th1) cells, which contribute to the secretion of inflammatory cytokines, augmenting M1 polarization and potentiating inflammation. Within 7 days of ICH ictus, the M1 phenotype coverts to a M2 phenotype, key for hematoma removal, tissue healing, and overall resolution of inflammation. The secretion of anti-inflammatory cytokines (e.g., IL-4, IL-10) can drive Th2 cell differentiation. M2 polarization is maintained by the secretion of additional antiinflammatory cytokines by the Th2 cells, suppressing M1 and Th1 phenotypes. Elucidating the timing and trigger of the anti-inflammatory phenotype may be integral in improving clinical outcomes. A challenge in current translational research is the absence of an equivalent disease animal model mirroring the patient population and comorbid pathophysiologic state. We review existing data and describe potential therapeutic targets around which we are creating a bench to bedside translational research model that better reflects the pathophysiology of ICH patients.

Abstract

Spontaneous intracerebral hemorrhage (ICH) is a catastrophic illness causing significant morbidity and mortality. Despite advances in surgical technique addressing primary brain injury caused by ICH, little progress has been made treating the subsequent inflammatory cascade. Pre-clinical studies have made advancements identifying components of neuroinflammation, including microglia, astrocytes, and T lymphocytes. After cerebral insult, inflammation is initially driven by the M1 microglia, secreting cytokines (e.g., interleukin-1β [IL-1β] and tumor necrosis factor-α) that are involved in the breakdown of the extracellular matrix, cellular integrity, and the blood brain barrier. Additionally, inflammatory factors recruit and induce differentiation of A1 reactive astrocytes and T helper 1 (Th1) cells, which contribute to the secretion of inflammatory cytokines, augmenting M1 polarization and potentiating inflammation. Within 7 days of ICH ictus, the M1 phenotype coverts to a M2 phenotype, key for hematoma removal, tissue healing, and overall resolution of inflammation. The secretion of anti-inflammatory cytokines (e.g., IL-4, IL-10) can drive Th2 cell differentiation. M2 polarization is maintained by the secretion of additional antiinflammatory cytokines by the Th2 cells, suppressing M1 and Th1 phenotypes. Elucidating the timing and trigger of the anti-inflammatory phenotype may be integral in improving clinical outcomes. A challenge in current translational research is the absence of an equivalent disease animal model mirroring the patient population and comorbid pathophysiologic state. We review existing data and describe potential therapeutic targets around which we are creating a bench to bedside translational research model that better reflects the pathophysiology of ICH patients.

참고문헌 (158)

  1. Qureshi AI, "Intracerebral haemorrhage", Lancet, 373, pp.1632~1644 (2009)
  2. van Asch CJ, "Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis", Lancet Neurol, 9, pp.167~176 (2010)
  3. Fogelholm R, "Long term survival after primary intracerebral haemorrhage : a retrospective population based study", J Neurol Neurosurg Psychiatry, 76, pp.1534~1538 (2005)
  4. Writing Group Members, "Heart disease and stroke statistics-2010 update : a report from the American Heart Association", Circulation, 121, pp.e46~e215 (2010)
  5. Qureshi AI, "Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001", Stroke, 38, pp.2180~2184 (2007)
  6. Adeoye O, "Advances in the management of intracerebral hemorrhage", Nat Rev Neurol, 6, pp.593~601 (2010)
  7. Xi G, "Mechanisms of brain injury after intracerebral haemorrhage", Lancet Neurol, 5, pp.53~63 (2006)
  8. Ariesen MJ, "Risk factors for intracerebral hemorrhage in the general population : a systematic review", Stroke, 34, pp.2060~2065 (2003)
  9. Broderick JP, "Volume of intracerebral hemorrhage : a powerful and easy-touse predictor of 30-day mortality", Stroke, 24, pp.987~993 (1993)
  10. Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2015, pp.46, 2032~2060
  11. Mould WA, "Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema", Stroke, 44, pp.627~634 (2013)
  12. Mendelow AD, "Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas(STICH II) : a randomised trial", Lancet, 382, pp.397~408 (2013)
  13. "Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (MISTIE-III)"[URL]
  14. "MIND: Artemis in the Removal of Intracerebral Hemorrhage" (2019)[URL]
  15. "ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) (ENRICH)" (2019)[URL]
  16. Wang J, "Inflammation after intracerebral hemorrhage", J Cereb Blood Flow Metab, 27, pp.894~908 (2007)
  17. Babu R, "Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention", Neurosurg Focus, 32, pp.E8~ (2012)
  18. Zhou Y, "Inflammation in intracerebral hemorrhage : from mechanisms to clinical translation", Prog Neurobiol, 115, pp.25~44 (2014)
  19. Wang J, "Preclinical and clinical research on inflammation after intracerebral hemorrhage", Prog Neurobiol, 92, pp.463~477 (2010)
  20. Aronowski J, "Molecular pathophysiology of cerebral hemorrhage : secondary brain injury", Stroke, 42, pp.1781~1786 (2011)
  21. Keep RF, "Intracerebral haemorrhage : mechanisms of injury and therapeutic targets", Lancet Neurol, 11, pp.720~731 (2012)
  22. Lawson LJ, "Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain", Neuroscience, 39, pp.151~170 (1990)
  23. Xiong XY, "Functions and mechanisms of microglia", macrophages in neuroinflammation and neurogenesis after stroke, 2016, pp.142, 23~44
  24. Boche D, "Review : activation patterns of microglia and their identification in the human brain", Neuropathol Appl Neurobiol, 39, pp.3~18 (2013)
  25. Salter MW, "Sublime microglia : expanding roles for the guardians of the CNS", Cell, 158, pp.15~24 (2014)
  26. Mosser DM, "Exploring the full spectrum of macrophage activation", Nat Rev Immunol, 8, pp.958~969 (2008)
  27. Wake H, "Microglia : actively surveying and shaping neuronal circuit structure and function", Trends Neurosci, 36, pp.209~217 (2013)
  28. Haynes SE, "The P2Y12 receptor regulates microglial activation by extracellular nucleotides", Nat Neurosci, 9, pp.1512~1519 (2006)
  29. Mildner A, "P2Y(12)receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases", Glia, 65, pp.375~387 (2017)
  30. Ransohoff RM, "Microglial physiology: unique stimuli, specialized responses", Annu Rev Immunol, 27, pp.119~145 (2009)
  31. Hidetoshi TS, "P2Y receptors in microglia and neuroinflammation", Wiley Interdiscip Rev Membr Transp Signal, 1, pp.493~501 (2012)
  32. Mracsko E, "Neuroinflammation after intracerebral hemorrhage", Front Cell Neurosci, 8, pp.388~ (2014)
  33. Taylor RA, "Microglial responses after ischemic stroke and intracerebral hemorrhage", Clin Dev Immunol, 2013, pp.746068~ (2013)
  34. Kanazawa M, "Microglia and monocytes", macrophages polarization reveal novel therapeutic mechanism against stroke, 2017, pp.18, E2135~
  35. Zhao H, "Microglia", macrophage polarization after experimental intracerebral hemorrhage, 2015, pp.6, 407~409
  36. Hu X, "Microglial and macrophage polarization : new prospects for brain repair", Nat Rev Neurol, 11, pp.56~64 (2015)
  37. Hu X, "Microglia", macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia, 2012, pp.43, 3063~3070
  38. Lan X, "Modulators of microglial activation and polarization after intracerebral haemorrhage", Nat Rev Neurol, 13, pp.420~433 (2017)
  39. Zhang Z, "Microglial polarization and inflammatory mediators after intracerebral hemorrhage", Mol Neurobiol, 54, pp.1874~1886 (2017)
  40. Eggen BJ, "Microglial phenotype and adaptation", J Neuroimmune Pharmacol, 8, pp.807~823 (2013)
  41. Wu J, "Microglial activation and brain injury after intracerebral hemorrhage", Acta Neurochir Suppl, 105, pp.59~65 (2008)
  42. Gomez-Nicola D, "Microglial dynamics and role in the healthy and diseased brain : a paradigm of functional plasticity", Neuroscientist, 21, pp.169~184 (2015)
  43. Varnum MM, "The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer’s disease brain", Arch Immunol Ther Exp(Warsz), 60, pp.251~266 (2012)
  44. da Fonseca AC, "The impact of microglial activation on bloodbrain barrier in brain diseases", Front Cell Neurosci, 8, pp.362~ (2014)
  45. Yang S, "Hemoglobininduced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat", J Mol Neurosci, 51, pp.352~363 (2013)
  46. Liu DZ, "Bloodbrain barrier breakdown and repair by Src after thrombin-induced injury", Ann Neurol, 67, pp.526~533 (2010)
  47. Yao Y, "Chemokines and their receptors in intracerebral hemorrhage", Transl Stroke Res, 3(Suppl 1), pp.70~79 (2012)
  48. Starossom SC, "Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration", Immunity, 37, pp.249~263 (2012)
  49. Saijo K, "Microglial cell origin and phenotypes in health and disease", Nat Rev Immunol, 11, pp.775~787 (2011)
  50. Franco R, "Alternatively activated microglia and macrophages in the central nervous system", Prog Neurobiol, 131, pp.65~86 (2015)
  51. Teng W, "Activation of TLR4-mediated NFκB signaling in hemorrhagic brain in rats", Mediators Inflamm, 2009, pp.473276~ (2009)
  52. Lin S, "Heme activates TLR4-mediated inflammatory injury via MyD88", TRIF signaling pathway in intracerebral hemorrhage, 2012, pp.9, 46~
  53. Sansing LH, "Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage", Ann Neurol, 70, pp.646~656 (2011)
  54. Fang H, "Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury", J Neuroinflammation, 10, pp.27~ (2013)
  55. Zhao X, "Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression", J Neurochem, 101, pp.652~663 (2007)
  56. Chhor V, "Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro", Brain Behav Immun, 32, pp.70~85 (2013)
  57. Yang J, "Interleukin-4 ameliorates the functional recovery of intracerebral hemorrhage through the alternative activation of microglia", macrophage, 2016, pp.10, 61~
  58. Husemann J, "Scavenger receptors in neurobiology and neuropathology : their role on microglia and other cells of the nervous system", Glia, 40, pp.195~205 (2002)
  59. Wang G, "Haematoma scavenging in intracerebral haemorrhage : from mechanisms to the clinic", J Cell Mol Med, 22, pp.768~777 (2018)
  60. Zhao X, "Hematoma resolution as a target for intracerebral hemorrhage treatment : role for peroxisome proliferator-activated receptor gamma in microglia", macrophages, 2007, pp.61, 352~362
  61. Xu H, "The polarization states of microglia in TBI : a new paradigm for pharmacological intervention", Neural Plast, 2017, pp.5405104~ (2017)
  62. Cherry JD, "Neuroinflammation and M2 microglia: the good, the bad, and the inflamed", J Neuroinflammation, 11, pp.98~ (2014)
  63. Xia CY, "Selective modulation of microglia polarization to M2 phenotype for stroke treatment", Int Immunopharmacol, 25, pp.377~382 (2015)
  64. Filardy AA, "Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high)regulatory phenotype in macrophages", J Immunol, 185, pp.2044~2050 (2010)
  65. Subramaniam SR, "Targeting microglial activation states as a therapeutic avenue in parkinson’s disease", Front Aging Neurosci, 9, pp.176~ (2017)
  66. Liang Z, "The emerging role of signal transducer and activator of transcription 3in cerebral ischemic and hemorrhagic stroke", Prog Neurobiol, 137, pp.1~16 (2016)
  67. Qin H, "Signal transducer and activator of transcription-3", suppressor of cytokine signaling-3(STAT3, Proc Natl Acad Sci U S A, pp.2012, 109[DOI]
  68. Lawrence T, "Transcriptional regulation of macrophage polarization : enabling diversity with identity", Nat Rev Immunol, 11, pp.750~761 (2011)
  69. Nguyen H, "Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression", J Biol Chem, 276, pp.33361~33368 (2001)
  70. Martinez-Nunez RT, "The interleukin 13(IL-13)pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1(IL13Ralpha1)", J Biol Chem, 286, pp.1786~1794 (2011)
  71. Sheldon KE, "Shaping the murine macrophage phenotype : IL-4 and cyclic AMP synergistically activate the arginase I promoter", J Immunol, 191, pp.2290~2298 (2013)
  72. Tsai MC, "Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats", J Pineal Res, 51, pp.233~245 (2011)
  73. Qin H, "SOCS3 deficiency promotes M1 macrophage polarization and inflammation", J Immunol, 189, pp.3439~3448 (2012)
  74. Koscsó B, "Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages", J Leukoc Biol, 94, pp.1309~1315 (2013)
  75. Zhao XR, "Pleiotropic role of PPARγin intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB", CNS Neurosci Ther, 21, pp.357~366 (2015)
  76. Kobayashi K, "Minocycline selectively inhibits M1 polarization of microglia", Cell Death Dis, 4, pp.e525~ (2013)
  77. Wasserman JK, "Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment", Brain Res, 1180, pp.140~154 (2007)
  78. Liddelow S, "SnapShot : astrocytes in health and disease", Cell, 162, pp.1170~1170 (2015)
  79. Scimemi A, "Astrocytes and the warning signs of intracerebral hemorrhagic stroke", Neural Plast, 2018, pp.7301623~ (2018)
  80. Jha MK, "Functional polarization of neuroglia : Implications in neuroinflammation and neurological disorders", Biochem Pharmacol, 103, pp.1~16 (2016)
  81. Jha MK, "Microglia-astrocyte crosstalk : an intimate molecular conversation", Neuroscientist, 25, pp.227~240 (2019)
  82. Liddelow SA, "Neurotoxic reactive astrocytes are induced by activated microglia", Nature, 541, pp.481~487 (2017)
  83. Lively S, "Age-related comparisons of evolution of the inflammatory response after intracerebral hemorrhage in rats", Transl Stroke Res, 3(Suppl 1), pp.132~146 (2012)
  84. Tejima E, "Astrocytic induction of matrix metalloproteinase-9and edema in brain hemorrhage", J Cereb Blood Flow Metab, 27, pp.460~468 (2007)
  85. Wang J, "Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage", Brain, 128(Pt 7), pp.1622~1633 (2005)
  86. Shavit E, "Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeet", J Neurochem, 119, pp.460~473 (2011)
  87. Sweeney AM, "PAR1 activation induces rapid changes in glutamate uptake and astrocyte morphology", Sci Rep, 7, pp.43606~ (2017)
  88. Chiu CD, "Inhibition of astrocytic activity alleviates sequela in acute stages of intracerebral hemorrhage", Oncotarget, 8, pp.94850~94861 (2017)
  89. Shichita T, "Post-ischemic inflammation in the brain", Front Immunol, 3, pp.132~ (2012)
  90. Hendrix S, "The role of T helper cells in neuroprotection and regeneration", J Neuroimmunol, 184, pp.100~112 (2007)
  91. Kivisäkk P, "Human cerebrospinal fluid central memory CD4+ T cells : evidence for trafficking through choroid plexus and meninges via P-selectin", Proc Natl Acad Sci U S A, 100, pp.8389~8394 (2003)
  92. Arumugam TV, "Stroke and T-cells", Neuromolecular Med, 7, pp.229~242 (2005)
  93. Yilmaz G, "Role of T lymphocytes and interferon-gamma in ischemic stroke", Circulation, 113, pp.2105~2112 (2006)
  94. Hurn PD, "T-and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation", J Cereb Blood Flow Metab, 27, pp.1798~1805 (2007)
  95. Liesz A, "Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke", Nat Med, 15, pp.192~199 (2009)
  96. Zhou K, "Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia", macrophage polarization through the IL-10, PTEN axis, pp.J Cereb Blood Flow Metab, 2017[DOI]
  97. Xue M, "Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats", J Stroke Cerebrovasc Dis, 12, pp.152~159 (2003)
  98. Loftspring MC, "Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes", J Cereb Blood Flow Metab, 29, pp.137~143 (2009)
  99. Guo FQ, "Study of relationship between inflammatory response and apoptosis in perihematoma region in patients with intracerebral hemorrhage", Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 18, pp.290~293 (2006)
  100. Iadecola C, "The immunology of stroke : from mechanisms to translation", Nat Med, 17, pp.796~808 (2011)
  101. Klebe D, "Modulating the immune response towards a neuroregenerative peri-injury milieu after cerebral hemorrhage", J Neuroimmune Pharmacol, 10, pp.576~586 (2015)
  102. Luckheeram RV, "CD4⁺T cells : differentiation and functions", Clin Dev Immunol, 2012, pp.925135~ (2012)
  103. Hwang ES, "T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3", Science, 307, pp.430~433 (2005)
  104. Lazarevic V, "T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt", Nat Immunol, 12, pp.96~104 (2011)
  105. Walker JA, "T(H)2 cell development and function", Nat Rev Immunol, 18, pp.121~133 (2018)
  106. Zhu J, "Stat6 is necessary and sufficient for IL-4’s role in Th2 differentiation and cell expansion", J Immunol, 166, pp.7276~7281 (2001)
  107. Kebir H, "Human TH17 lymphocytes promote bloodbrain barrier disruption and central nervous system inflammation", Nat Med, 13, pp.1173~1175 (2007)
  108. Kleinewietfeld M, "The plasticity of human Treg and Th17 cells and its role in autoimmunity", Semin Immunol, 25, pp.305~312 (2013)
  109. Gao L, "Transplanted neural stem cells modulate regulatory T, γδ T cells and corresponding cytokines after intracerebral hemorrhage in rats", Int J Mol Sci, 15, pp.4431~4441 (2014)
  110. Mao LL, "Adoptive regulatory t-cell therapy attenuates perihematomal inflammation in a mouse model of experimental intracerebral hemorrhage", Cell Mol Neurobiol, 37, pp.919~929 (2017)
  111. Murray PJ, "Obstacles and opportunities for understanding macrophage polarization", J Leukoc Biol, 89, pp.557~563 (2011)
  112. Biswas SK, "Macrophage plasticity and interaction with lymphocyte subsets : cancer as a paradigm", Nat Immunol, 11, pp.889~896 (2010)
  113. Yang Z, "Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage", Int Immunopharmacol, 22, pp.522~525 (2014)
  114. Ren X, "Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke", Stroke, 42, pp.2578~2583 (2011)
  115. Mracsko E, "Leukocyte invasion of the brain after experimental intracerebral hemorrhage in mice", Stroke, 45, pp.2107~2114 (2014)
  116. Kondo A, "Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes", Blood, 116, pp.1124~1131 (2010)
  117. Selenko-Gebauer N, "B7-H1(programmed death-1 ligand)on dendritic cells is involved in the induction and maintenance of T cell anergy", J Immunol, 170, pp.3637~3644 (2003)
  118. Okazaki T, "A rheostat for immune responses : the unique properties of PD-1and their advantages for clinical application", Nat Immunol, 14, pp.1212~1218 (2013)
  119. Ostrand-Rosenberg S, "The programmed death-1 immune-suppressive pathway : barrier to antitumor immunity", J Immunol, 193, pp.3835~3841 (2014)
  120. Dai S, "The PD-1", PD-Ls pathway and autoimmune diseases, 2014, pp.290, 72~79
  121. Jin HT, "Role of PD-1 in regulating T-cell immunity", Curr Top Microbiol Immunol, 350, pp.17~37 (2011)
  122. Lee YJ, "Macrophage PD-L1 strikes back : PD-1", PD-L1 interaction drives macrophages toward regulatory subsets, 2013, pp.4, 19~29
  123. Bodhankar S, "PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1", J Neuroinflammation, 10, pp.111~ (2013)
  124. Zhao S, "Regulation of neuroinflammation through programed death-1", programed death ligand signaling in neurological disorders, 2014, pp.8, 271~
  125. Yuan B, "Programmed death(PD)-1 attenuates macrophage activation and brain inflammation via regulation of fibrinogen-like protein 2(Fgl-2)after intracerebral hemorrhage in mice", Immunol Lett, 179, pp.114~121 (2016)
  126. Han R, "PD-L1(programmed death ligand 1)protects against experimental intracerebral hemorrhage-induced brain injury", Stroke, 48, pp.2255~2262 (2017)
  127. Wu J, "Roles of programmed death protein 1", programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats : selective modulation of microglia polarization to anti-inflammatory phenotype, 2017, pp.14, 36~
  128. Cohen JA, "Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis", Ann Neurol, 69, pp.759~777 (2011)
  129. Chun J, "Mechanism of action of oral fingolimod(FTY720)in multiple sclerosis", Clin Neuropharmacol, 33, pp.91~101 (2010)
  130. Rosen H, "Sphingosine-1-phosphate and its receptors: structure, signaling, and influence", Annu Rev Biochem, 82, pp.637~662 (2013)
  131. Baeyens A, "Exit strategies : S1P signaling and T cell migration", Trends Immunol, 36, pp.778~787 (2015)
  132. Garris CS, "Sphingosine-1-phosphate receptor 1 signalling in T cells : trafficking and beyond", Immunology, 142, pp.347~353 (2014)
  133. Kappos L, "A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis", N Engl J Med, 362, pp.387~401 (2010)
  134. Calabresi PA, "Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3trial", Lancet Neurol, 13, pp.545~556 (2014)
  135. Groves A, "Fingolimod : direct CNS effects of sphingosine 1-phosphate(S1P)receptor modulation and implications in multiple sclerosis therapy", J Neurol Sci, 328, pp.9~18 (2013)
  136. Chiba K, "FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors", Pharmacol Ther, 108, pp.308~319 (2005)
  137. Chang Wook Lee, "Neurological S1P Signaling as an Emerging Mechanism of Action of Oral FTY720 (Fingolimod) in Multiple Sclerosis", Archives of Pharmacal Research, 33(10), pp.1567~1574 (2010), 대한약학회
  138. Tham CS, "Microglial activation state and lysophospholipid acid receptor expression", Int J Dev Neurosci, 21, pp.431~443 (2003)
  139. Okada T, "Sphingosine kinase", sphingosine 1-phosphate signalling in central nervous system, 2009, pp.21, 7~13
  140. Melendez AJ, "Sphingosine kinase signalling in immune cells : potential as novel therapeutic targets", Biochim Biophys Acta, 1784, pp.66~75 (2008)
  141. Nayak D, "Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia", Neuroscience, 166, pp.132~144 (2010)
  142. Noda H, "Fingolimod phosphate promotes the neuroprotective effects of microglia", J Neuroimmunol, 256, pp.13~18 (2013)
  143. Rothhammer V, "Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation", Proc Natl Acad Sci U S A, 114, pp.2012~2017 (2017)
  144. Qin C, "Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3pathway", Stroke, 48, pp.3336~3346 (2017)
  145. Das A, "FTY720(fingolimod)regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing", Neuropharmacology, 119, pp.1~14 (2017)
  146. Sucksdorff M, "Evaluation of the effect of fingolimod treatment on microglial activation using serial pet imaging in multiple sclerosis", J Nucl Med, 58, pp.1646~1651 (2017)
  147. Delbridge MS, "Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine", Transplantation, 84, pp.187~195 (2007)
  148. Man K, "FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers", Am J Transplant, 5, pp.40~49 (2005)
  149. Hasegawa Y, "Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats", Stroke, 41, pp.368~374 (2010)
  150. Wei Y, "Fingolimod provides long-term protection in rodent models of cerebral ischemia", Ann Neurol, 69, pp.119~129 (2011)
  151. Fu Y, "Impact of an immune modulator fingolimod on acute ischemic stroke", Proc Natl Acad Sci U S A, 111, pp.18315~18320 (2014)
  152. Zhu Z, "Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke : a pilot trial", Circulation, 132, pp.1104~1112 (2015)
  153. Lu L, "Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage", Brain Res, 1555, pp.89~96 (2014)
  154. Rolland WB, "Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage", Exp Neurol, 241, pp.45~55 (2013)
  155. Sun N, "Selective sphingosine-1-phosphate receptor 1 modulation attenuates experimental intracerebral hemorrhage", Stroke, 47, pp.1899~1906 (2016)
  156. Fu Y, "Fingolimod for the treatment of intracerebral hemorrhage : a 2-arm proof-of-concept study", JAMA Neurol, 71, pp.1092~1101 (2014)
  157. Wei Y, "NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat", Hypertension, 50, pp.384~391 (2007)
  158. Paoletti R, "Metabolic syndrome, inflammation and atherosclerosis", Vasc Health Risk Manag, 2, pp.145~152 (2006)

관련 논문AI추천

Postischemic Inflammation in Acute StrokeArturo Consoli, Domenico Consoli, Marco Arnaboldi, Simone Vidale대한신경과학회 · Journal of Clinical Neurology2017 · 제13권 제1호Spontaneous Intracerebral Hemorrhage: Management김준엽, 배희준대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제1호Intracerebral Hemorrhage: Large Disease Burden but Less Therapeutic Progress강동화대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제1호Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease양승훈대한배뇨장애요실금학회 · International Neurourology Journal2019 · 제23권 제1호The pivotal role of the NLRC4 inflammasome in neuroinflammation after intracerebral hemorrhage in ratsChen Hui, Gan Hui, Jiang Ning, Liang Ping, Wang Lu, Xiao Han, Zhai Xuan, Zhang Li, Zhao Jing, Zheng Shuyue생화학분자생물학회 · Experimental and Molecular Medicine2021 · 제53권 Angiopoietin-1 and Angiopoietin-2 Expression Imbalance Influence in Early Period After Subarachnoid HemorrhageChao-Hui Zhao, Hua Gu, Jian-Guo Yang, Xing-Ming Zhong, Yi-Qi Wang, Yong Cai, Zhen-Hai Fei대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제4호

이 간행물의 다른 논문 (13건)

Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique PathomechanismsMi Ji Lee, Woo-Keun Seo, Gyeong-Moon Kim, Oh Young Bang, OASIS-Cancer Study Investigators, Jong-Won Chung, Myung-Ju Ahnpp. 1-10Depression after Subarachnoid Hemorrhage: A Systematic ReviewKelvin K.F. Tsoi, Jong S. Kim, Wai Kwong Tang, Lisha Wang, George Kwok Chu Wong, Gabor S. Ungvari, Fumihiko Yasunopp. 11-28Rewiring the Lesioned Brain: Electrical Stimulation for Post-Stroke Motor RestorationAhsan Khan, Shi-chun Bao, Rong Song, Raymond Kai-yu Tongpp. 47-63Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in StrokeDong Joon Kim, Ji Hoe Heo, Byung Moon Kim, Young Dae Kim, Il Kwon, Hyo Suk Nam, Jin Kyo Choipp. 64-75Prevalence of Intracranial Aneurysm in Patients with Aortopathy: A Systematic Review with Meta-AnalysesShiyi Cao, Yupeng Wei, Qingqing Jiang, Liangtao Xia, Xinyu Yu, Xiang Weipp. 76-86
원문 보기